Ophthotech Corp. | Mutual Funds
Mutual Funds that own Ophthotech Corp.
Vanguard Total Stock Market Index Fund
891,106
2.47%
8,335
0%
07/31/2018
Vanguard Explorer Fund
420,409
1.15%
0
0.01%
06/30/2018
GO UCITS ETF Solutions Plc - Longer Dated All Commodities
340,360
0.94%
-30,850
0.16%
02/28/2018
340,360
0.94%
340,360
4.3%
02/28/2018
340,360
0.94%
340,360
3.82%
02/28/2018
Vanguard Extended Market Index Fund
338,646
0.94%
11,823
0%
07/31/2018
State of Wisconsin Invt. Board-Core Retirement Invt. Trust Fd.
247,476
0.69%
247,476
0%
12/31/2016
Fidelity Spartan Extended Market Index Fund
123,408
0.34%
0
0%
07/31/2018
DFA US Small Cap Portfolio
119,558
0.33%
82,546
0%
04/30/2018
DFA US Targeted Value Portfolio
106,479
0.3%
78,335
0%
04/30/2018
| Address |
One Penn Plaza
New York New York 10119
United States
|
|
Employees
|
- |
| Website |
http://www.ophthotech.com |
| Updated |
09/14/2018 |
| Ophthotech Corp. is a biopharmaceutical company,which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. |
